Do you want to read an article? Please log in or register.
Differentiation stage of myeloma plasma cells: biological and clinical significance
Multiple Myeloma (MM)
Related content
RECOMMENDED
Multiple Myeloma (MM)
Biological and clinical significance of dysplastic hematopoiesis in patients with newly-diagnosed multiple myeloma
★ 1
Recommended by
Prof. Dr Stephan Bodis, Faculty Member
★ 1
Recommended by
Prof. Dr Christoph Renner, Faculty Member
doi: 10.1182/blood.2019003382.
Multiple Myeloma (MM)
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma
Cytotherapy.
Tschan-Plessl A, Kalberer CP, Wieboldt R, Stern M, Siegler U, Wodnar-Filipowicz A, Gerull S, Halter J, Heim D, Tichelli A, Tsakiris DA, Malmberg KJ, Passweg JR, Bottos A
doi: 10.1016/j.jcyt.2020.09.009.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial
JAMA Oncol.
Salem A, Mistry H, Hatton M, Locke I, Monnet I, Blackhall F, Faivre-Finn C
doi: 10.1001/jamaoncol.
Multiple Myeloma (MM)
Outcomes of lenalidomide- or bortezomib-based regimens in older patients with plasma cell myeloma
Am J Hematol.
Barth P, Giri S, Reagan JL, Olszewski AJ
doi: 10.1002/ajh.25996.
Multiple Myeloma (MM)
The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma
Br J Haematol
Galieni P, Travaglini F, Vagnoni D, Ruggieri M, Caraffa P, Bigazzi C, Falcioni S, Picardi P, Mazzotta S, Troiani E, Dalsass A, Mestichelli F, Angelini M, Camaioni E, Maravalle D, Angelini S, Pezzoni V
doi: 10.1111/bjh.17118
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer
JAMA Oncol.
Aggarwal C, Thompson JC, Black TA, Katz SI, Fan R, Yee SS, Chien AL, Evans TL, Bauml JM, Alley EW, Ciunci CA, Berman AT, Cohen RB, Lieberman DB, Majmundar KS, Savitch SL, Morrissette JJD, Hwang WT, Elenitoba-Johnson KSJ, Langer CJ, Carpenter EL
doi: 10.1001/
Multiple Myeloma (MM)
Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
Swiss Med Wkly.
Samaras P, Bargetzi M, Betticher DC, Driessen C, Duchosal MA, Heim D, Ketterer N, Lerch E, Matthes T, Mey U, Pabst T, Schmidt A, Taverna C, Zander T, Renner C
doi: 10.4414/smw.2019.20031
Multiple Myeloma (MM)
Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy
J Cancer Res Clin Oncol.
Danhof S, Strifler S, Hose D, Kortüm M, Bittrich M, Hefner J, Einsele H, Knop S, Schreder M
doi: 10.1007/s00432-018-2807-1.
SPECIAL REPORT
Skin Cancer